iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis

An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database

Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484

Disease-Specific Induced Pluripotent Stem Cells.

Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135

The Proteomics Identifications (PRIDE) database and associated tools: status in 2013

Vizcaíno, J. A., Côté, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1262 · Cited by 1,918

Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease

Kriks, S., Shim, J.-W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo-Reid, L., Auyeung, G., Antonacci, C., Buch, A., et al. (2011) · Nature · doi:10.1038/nature10648 · Cited by 1,907

Filter-paper partition chromatography of sugars

Partridge, S. M. (1948) · Biochemical Journal · doi:10.1042/bj0420238 · Cited by 1,790

A tissue-specific atlas of mouse protein phosphorylation and expression

Huttlin, E. L., Jedrychowski, M. P., Elias, J. E., Goswami, T., Rad, R., Beausoleil, S. A., Villén, J., Haas, W., Sowa, M. E., & Gygi, S. P. (2010) · Cell · doi:10.1016/j.cell.2010.12.001 · Cited by 1,778

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341

Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253

MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics

Ting, L., Rad, R., Gygi, S. P., & Haas, W. (2011) · Nature Methods · doi:10.1038/nmeth.1714 · Cited by 1,009

SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

Litvan, I., Bhatia, K. P., Burn, D. J., Goetz, C. G., Lang, A. E., McKeith, I., Quinn, N., Sethi, K. D., Shults, C., & Wenning, G. K. (2003) · Movement Disorders · doi:10.1002/mds.10459 · Cited by 1,009

Increasing the Multiplexing Capacity of TMTs Using Reporter Ion Isotopologues with Isobaric Masses

McAlister, G. C., Huttlin, E. L., Haas, W., Ting, L., Jedrychowski, M. P., Rogers, J. C., Kuhn, K., Pike, I., Grothe, R. A., Blethrow, J. D., et al. (2012) · Analytical Chemistry · doi:10.1021/ac301572t · Cited by 605

α-Synuclein Membrane Interactions and Lipid Specificity

Jo, E., McLaurin, J., Yip, C. M., St. George-Hyslop, P., & Fraser, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004345200 · Cited by 604

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains

Gegg, M. E., Burke, D., Heales, S. J. R., Cooper, J. M., Hardy, J., Wood, N. W., & Schapira, A. H. V. (2012) · Annals of Neurology · doi:10.1002/ana.23614 · Cited by 564

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease

Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., McLean, J. R., Carrillo-Reid, L., Xie, Z., Osborn, T., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003985 · Cited by 508

Genetic Correction of a LRRK2 Mutation in Human iPSCs Links Parkinsonian Neurodegeneration to ERK-Dependent Changes in Gene Expression

Reinhardt, P., Schmid, B., Burbulla, L. F., Schöndorf, D. C., Wagner, L., Glatza, M., Höing, S., Hargus, G., Heck, S. A., Dhingra, A., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.008 · Cited by 502

A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies

Nalls, M. A., Duran, R., Lopez, G., Kurzawa-Akanbi, M., McKeith, I. G., Chinnery, P. F., Morris, C. M., Theuns, J., Crosiers, D., Cras, P., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1925 · Cited by 439

Robust Pacemaking in Substantia Nigra Dopaminergic Neurons

Guzman, J. N., Sánchez-Padilla, J., Chan, C. S., & Surmeier, D. J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2519-09.2009 · Cited by 411

Occurrence of Parkinson's syndrome in type 1 Gaucher disease

Neudorfer, O., Giladi, N., Elstein, D., Abrahamov, A., Turezkite, T., Aghai, E., Reches, A., Bembi, B., & Zimran, A. (1996) · QJM · doi:10.1093/qjmed/89.9.691 · Cited by 401

Altered lipid content inhibits autophagic vesicular fusion

Koga, H., Kaushik, S., & Cuervo, A. M. (2010) · The FASEB Journal · doi:10.1096/fj.09-144519 · Cited by 395

Cell-Surface Marker Signatures for the Isolation of Neural Stem Cells, Glia and Neurons Derived from Human Pluripotent Stem Cells

Yuan, S. H., Martin, J., Elia, J., Flippin, J., Paramban, R. I., Hefferan, M. P., Vidal, J. G., Mu, Y., Killian, R. L., Israel, M. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017540 · Cited by 380

Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease—Links to Parkinson’s Disease

Osellame, L. D., Rahim, A. A., Hargreaves, I. P., Gegg, M. E., Richard-Londt, A., Brandner, S., Waddington, S. N., Schapira, A. H. V., & Duchen, M. R. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.014 · Cited by 334

Markers and Methods for Cell Sorting of Human Embryonic Stem Cell-Derived Neural Cell Populations

Pruszak, J., Sonntag, K.-C., Aung, M. H., Sanchez-Pernaute, R., & Isacson, O. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0744 · Cited by 320

CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy

Sardi, S. P., Clarke, J., Kinnecom, C., Tamsett, T. J., Li, L., Stanek, L. M., Passini, M. A., Grabowski, G. A., Schlossmacher, M. G., Sidman, R. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108197108 · Cited by 319

Human brain gangliosides: developmental changes from early fetal stage to advanced age

Svennerholm, L., Boström, K., Fredman, P., Månsson, J.-E., Rosengren, B., & Rynmark, B.-M. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90175-6 · Cited by 284

GBA-associated PD presents with nonmotor characteristics

Brockmann, K., Srulijes, K., Hauser, A.-K., Schulte, C., Csoti, I., Gasser, T., & Berg, D. (2011) · Neurology · doi:10.1212/wnl.0b013e318225ab77 · Cited by 268

Genetic variability in the SNCA gene influences α‐synuclein levels in the blood and brain

Fuchs, J., Tichopad, A., Golub, Y., Munz, M., Schweitzer, K. J., Wolf, B., Berg, D., Mueller, J. C., & Gasser, T. (2008) · The FASEB Journal · doi:10.1096/fj.07-9348com · Cited by 247

CD15, CD24, and CD29 Define a Surface Biomarker Code for Neural Lineage Differentiation of Stem Cells

Pruszak, J., Ludwig, W., Blak, A., Alavian, K., & Isacson, O. (2009) · Stem Cells · doi:10.1002/stem.211 · Cited by 227

The risk of Parkinson's disease in type 1 Gaucher disease

Bultron, G., Kacena, K., Pearson, D., Boxer, M., Yang, R., Sathe, S., Pastores, G., & Mistry, P. K. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9055-0 · Cited by 223

Mutation of β-glucosidase 2 causes glycolipid storage disease and impaired male fertility

Yildiz, Y., Matern, H., Thompson, B., Allegood, J. C., Warren, R. L., Ramirez, D. M. O., Hammer, R. E., Hamra, F. K., Matern, S., & Russell, D. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29224 · Cited by 222

Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains

Ngamukote, S., Yanagisawa, M., Ariga, T., Ando, S., & Yu, R. K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04910.x · Cited by 217

Generation of Specific Deoxynojirimycin-type Inhibitors of the Non-lysosomal Glucosylceramidase

Overkleeft, H. S., Renkema, G. H., Neele, J., Vianello, P., Hung, I. O., Strijland, A., van der Burg, A. M., Koomen, G.-J., Pandit, U. K., & Aerts, J. M. F. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26522 · Cited by 186

Identification of the Non-lysosomal Glucosylceramidase as β-Glucosidase 2

Boot, R. G., Verhoek, M., Donker-Koopman, W., Strijland, A., van Marle, J., Overkleeft, H. S., Wennekes, T., & Aerts, J. M. F. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610544200 · Cited by 185

Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders

Goker-Alpan, O., Stubblefield, B. K., Giasson, B. I., & Sidransky, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0741-7 · Cited by 181

Loss of Function of Glucocerebrosidase GBA2 Is Responsible for Motor Neuron Defects in Hereditary Spastic Paraplegia

Martin, E., Schüle, R., Smets, K., Rastetter, A., Boukhris, A., Loureiro, J. L., Gonzalez, M. A., Mundwiller, E., Deconinck, T., Wessner, M., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.11.021 · Cited by 180

Changes in the Lipid Turnover, Composition, and Organization, as Sphingolipid-enriched Membrane Domains, in Rat Cerebellar Granule Cells Developing in Vitro

Prinetti, A., Chigorno, V., Prioni, S., Loberto, N., Marano, N., Tettamanti, G., & Sonnino, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010666200 · Cited by 177

Parkinson’s disease is associated with altered expression of CaV1 channels and calcium-binding proteins

Hurley, M. J., Brandon, B., Gentleman, S. M., & Dexter, D. T. (2013) · Brain · doi:10.1093/brain/awt134 · Cited by 177

Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism

Manning-Boğ, A. B., Schüle, B., & Langston, J. W. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.06.009 · Cited by 176

Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond

Shachar, T., Bianco, C. L., Recchia, A., Wießner, C., Raas‐Rothschild, A., & Futerman, A. H. (2011) · Movement Disorders · doi:10.1002/mds.23774 · Cited by 153

The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders

Velayati, A., Yu, W. H., & Sidransky, E. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0102-x · Cited by 152

Enhanced calcium release in the acute neuronopathic form of Gaucher disease

Pelled, D., Trajkovic‐Bodennec, S., Lloyd‐Evans, E., Sidransky, E., Schiffmann, R., & Futerman, A. H. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.004 · Cited by 146

Exploring the link between glucocerebrosidase mutations and parkinsonism

Westbroek, W., Gustafson, A. M., & Sidransky, E. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.003 · Cited by 145

Identification of embryonic stem cell–derived midbrain dopaminergic neurons for engraftment

Ganat, Y. M., Calder, E. L., Kriks, S., Nelander, J., Tu, E. Y., Jia, F., Battista, D., Harrison, N. L., Parmar, M., Tomishima, M. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58767 · Cited by 141

Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models

Xu, Y. H., Sun, Y., Ran, H., Quinn, B., Witte, D. P., & Grabowski, G. A. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.12.014 · Cited by 139

Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease

van Weely, S., Brandsma, M., Strijland, A., Tager, J. M., & Aerts, J. M. F. G. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(93)90090-n · Cited by 137

Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease

Panicker, L. M., Miller, D., Park, T. S., Patel, B., Azevedo, J. L., Awad, O., Masood, M. A., Veenstra, T. D., Goldin, E., Stubblefield, B. K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207889109 · Cited by 129

Endogenous Calcium Buffering Capacity of Substantia Nigral Dopamine Neurons

Foehring, R. C., Zhang, X. F., Lee, J. C. F., & Callaway, J. C. (2009) · Journal of Neurophysiology · doi:10.1152/jn.00038.2009 · Cited by 127

Mutations in GBA2 Cause Autosomal-Recessive Cerebellar Ataxia with Spasticity

Hammer, M. B., Eleuch-Fayache, G., Schottlaender, L., Nehdi, H., Gibbs, J. R., Arepalli, S. K., Chong, S., Hernandez, D. G., Sailer, A., Liu, G., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.12.012 · Cited by 126

Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease

Balducci, C., Pierguidi, L., Persichetti, E., Parnetti, L., Sbaragli, M., Tassi, C., Orlacchio, A., Calabresi, P., Beccari, T., & Rossi, A. (2007) · Movement Disorders · doi:10.1002/mds.21399 · Cited by 121

Unfolded protein response in Gaucher disease: from human to Drosophila

Maor, G., Rencus‐Lazar, S., Filocamo, M., Steller, H., Segal, D., & Horowitz, M. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-140 · Cited by 114

Plasma membrane production of ceramide from ganglioside GM3 in human fibroblasts

Valaperta, R., Chigorno, V., Basso, L., Prinetti, A., Bresciani, R., Preti, A., Miyagi, T., & Sonnino, S. (2006) · The FASEB Journal · doi:10.1096/fj.05-5077fje · Cited by 113

The Non-lysosomal β-Glucosidase GBA2 Is a Non-integral Membrane-associated Protein at the Endoplasmic Reticulum (ER) and Golgi

Körschen, H. G., Yildiz, Y., Raju, D. N., Schonauer, S., Bönigk, W., Jansen, V., Kremmer, E., Kaupp, U. B., & Wachten, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.414714 · Cited by 100

Topographical Atlas of the Gangliosides of the Adult Human Brain

Kraĉun, I., Rösner, H., Ćosović, Č., et al. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb12833.x · Cited by 92

Acute action of rotenone on nigral dopaminergic neurons – involvement of reactive oxygen species and disruption of Ca2+ homeostasis

Freestone, P. S., Chung, K. K. H., Guatteo, E., Mercuri, N. B., Nicholson, L. F. B., & Lipski, J. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06990.x · Cited by 85

Cerebrospinal fluid β-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies

Parnetti, L., Balducci, C., Pierguidi, L., Carlo, C. D., Peducci, M., D’Amore, C., Padiglioni, C., Mastrocola, S., Persichetti, E., Paciotti, S., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.03.002 · Cited by 71

NECABs: a family of neuronal Ca2+-binding proteins with an unusual domain structure and a restricted expression pattern

Sugita, S., Ho, A., & Südhof, T. C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00063-5 · Cited by 55

Development of Histocompatible Primate‐Induced Pluripotent Stem Cells for Neural Transplantation

Deleidi, M., Hargus, G., Hallett, P. J., Osborn, T. M., & Ole Isacson, A. (2011) · Stem Cells · doi:10.1002/stem.662 · Cited by 49

Combined Flow Cytometric Analysis of Surface and Intracellular Antigens Reveals Surface Molecule Markers of Human Neuropoiesis

Turaç, G., Hindley, C. J., Thomas, R., Davis, J. A., Deleidi, M., Gasser, T., Karaöz, E., & Pruszak, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068519 · Cited by 48

Calcium dysregulation in Parkinson’s disease

Schapira, A. H. V. (2013) · Brain · doi:10.1093/brain/awt180 · Cited by 47

Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts

Aureli, M., Bassi, R., Loberto, N., Regis, S., Prinetti, A., Chigorno, V., Aerts, J. M. F. G., Boot, R. G., Filocamo, M., & Sonnino, S. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9478-x · Cited by 44

The neuronal Ca2+-binding protein 2 (NECAB2) interacts with the adenosine A2A receptor and modulates the cell surface expression and function of the receptor

Canela, L., Luján, R., Lluı́s, C., Burgueño, J., Mallol, J., Canela, E. I., Franco, R., & Ciruela, F. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.05.007 · Cited by 43

Mass Spectrometry Based Method to Increase Throughput for Kinome Analyses Using ATP Probes

McAllister, F. E., Niepel, M., Haas, W., Huttlin, E. L., Sorger, P. K., & Gygi, S. P. (2013) · Analytical Chemistry · doi:10.1021/ac303478g · Cited by 36

Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes

Burke, D. G., Rahim, A. A., Waddington, S. N., et al. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9561-3 · Cited by 34

Rotenone induces neurotoxicity through Rac1‐dependent activation of NADPH oxidase in SHSY‐5Y cells

Pal, R., Monroe, T. O., Palmieri, M., Sardiello, M., & Rodney, G. G. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.12.011 · Cited by 34

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1

Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897

Induced pluripotent stem cell technology: a decade of progress.

Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.245 · Cited by 1,525

Defects in trafficking bridge Parkinson’s disease pathology and genetics

Abeliovich, A., & Gitler, A. D. (2016) · Nature · doi:10.1038/nature20414 · Cited by 462

The Role of Autophagy in Parkinson's Disease

Lynch-Day, M. A., Mao, K., Wang, K., Zhao, M., & Klionsky, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009357 · Cited by 458

α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models

Mazzulli, J. R., Zunke, F., Isacson, O., Studer, L., & Krainc, D. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520335113 · Cited by 386